Delivery Order SPE2DB20D2104-SPE2DB25FMFPW

Award Date 1/7/25
Potential Completion Date 1/8/25
Potential Value $3.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,987.91 fixed-price delivery order is for the provision of MIEBO 100% Eye Drop 3ML medical supplies, with an ultimate completion date of December 31, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,448.13 Firm Fixed Price delivery order contract covers the supply of MIEBO 100% Eye Drop 3ML, a medical product, with a completion date of December 27, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,246.14 Firm Fixed Price Delivery Order contract is for the supply of MIEBO 100% Eye Drop 3ML, a medical product. The contract has an ultimate completion date of April 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award, valued at $1,861.51, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MIEBO 100% EYE DROP 3ML medical products, with a completion date of January 8, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $1,399.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under a DLA Indefinite Delivery Contract (IDC), is for the delivery of "MIEBO 100% EYE DROP 3ML". The IDC has a ceiling value of $999,999,999 and runs through November 2026, enabling efficient procurement of a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, a Delivery Order contract worth $40,481.51 for the supply of MIEBO 100% eye drops. This contract has a completion date of May 30, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,391.68 firm fixed-price delivery order is for the supply of MIEBO 100% Eye Drop 3ML, a pharmaceutical product. The contract has an ultimate completion date of November 18, 2024 and does not utilize any set-aside requirements, indicating open competition. AmerisourceBergen holds a significant $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,015.65, is a Delivery Order with a Firm Fixed Price pricing type. It covers the provision of MIEBO 100% EYE DROP 3ML medical products, with a completion date of January 3, 2025. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds...
This federal contract award, valued at $2,136.84, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of MIEBO 100% EYE DROP 3ML medical products. The contract has an ultimate completion date of November 5, 2024 and is structured as a Firm Fixed Price Delivery Order. There is no set-aside designation mentioned for this award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award, valued at $3,340.52, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MIEBO 100% Eye Drop 3ML, a pharmaceutical product, with a completion date of November 7, 2024. This award is structured as a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25FMFPW
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $3,516.05, is a Delivery Order for medical supplies including the "MIEBO 100% EYE DROP 3ML" product. The contract has a firm fixed price pricing type and a period of performance through January 8, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award did not utilize any set-aside designations, indicating open competition. The award is associated with the larger IDC contract vehicles held by Amerisourcebergen, demonstrating the company's position as a critical supplier of pharmaceutical and medical products to federal agencies, particularly the DLA and Department of Justice.

Generated 4/8/25, 9:58 AM